🚀 RECENT AI SUCCESS

Our AI successfully predicted the gap for $HLT and executed a BUY strategy, securing a +1.48% net profit.

UPGRADE TO SEE LIVE SIGNALS

$TERN

Terns Pharmaceuticals Inc

United StatesUNITED STATES
FREE PREVIEW
🌐 Website🏛️ NASDAQ📁 Health Technology🏭 Biotechnology
AVG HISTORICAL GAP2.75%
MAX GAP RECORD10.81%
PREMIUM
AI ACCURACY RATE
92.4%
Unlock AI Insights 🔓

LAST 10 EARNINGS GAPS (%)

VOLATILITY & BIAS PROFILE

AVG VOLATILITY3.3%
Bullish Gaps
Bearish Gaps
Neutral

Intelligence Brief

Terns Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company, which engages in developing a portfolio of small-molecule single-agent and combination therapy candidates for the treatment of non-alcoholic steatohepatitis, or NASH, and other chronic liver diseases. The firm's pipeline includes clinical stage development programs, including a FXR agonist, a VAP-1 inhibitor, a THR-ß agonist, and a preclinical GLP-1 receptor agonist program. The… Read full dossier

CURRENT AI SIGNAL
BULLISH STRONG
🔓 REVEAL SIGNAL

AI INSIGHTS & REPORTS FOR TERN

AI REPORT Jul 24

Balanced Portfolio Strategies in Turbulent Markets

AnalysisMarkets are in a state of heightened volatility, with sentiment shifting rapidly as investors grapple with geopolitical tensions…
VIEW REPORT_
AI REPORT Jul 23

Quantitative Portfolio Strategies: Balancing Risk and Reward in Volatile Markets

Analysis Markets are increasingly volatile as global economic uncertainties persist, with tech stocks leading the charge. Recent developments…
VIEW REPORT_
AI REPORT Jul 23

Unveiling ACE.MI: A Deep Dive into Earnings Anticipation

Analysis Markets are buzzing with anticipation as $ACE.MI prepares to reveal its earnings, setting the stage for potential…
VIEW REPORT_
AI MARKET SCANNING